Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong · Delayed Price · Currency is HKD 16.65
+0.07 (0.42%)
Aug 21, 2026, 4:08 PM HKT
Sinopharm Group Market Cap
Sinopharm Group has a market cap or net worth of 51.96 billion as of August 21, 2026. Its market cap has decreased by -15.53% in one year.
Market Cap
51.96B
Enterprise Value
154.67B
Revenue
652.76B
Ranking
n/a
PE Ratio
6.46
Stock Price
16.65
ChartMarket Cap Chart
Since September 23, 2009, Sinopharm Group's market cap has increased from 40.42B to 51.96B, an increase of 28.54%. That is a compound annual growth rate of 1.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 51.96B | -14.35% |
| Dec 31, 2025 | 60.67B | -8.73% |
| Dec 31, 2024 | 66.47B | 4.16% |
| Dec 29, 2023 | 63.82B | 3.07% |
| Dec 30, 2022 | 61.91B | 16.98% |
| Dec 31, 2021 | 52.93B | -10.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 160 Health International | 3.36B |
| Sipai Health Technology | 1.11B |
| ETHK Labs | 962.57M |
| Charmacy Pharmaceutical | 594.00M |
| China Health Group | 409.21M |
| ClouDr Group | 329.32M |
| Sinco Pharmaceuticals Holdings | 325.26M |
| Wanjia Group Holdings | 146.72M |